02 Oct
|
Immix Biopharma (Nasdaq: IMMX)
|
Toronto
02 Oct
Immix Biopharma (Nasdaq: IMMX)
Toronto
Immix Biopharma, Inc. is seeking a Clinical Trial Site Activation Specialist to drive end-to-end site activation during study start-up in a hybrid Toronto setting. You will coordinate regulatory submissions, budget discussions, and essential document collection to ensure timely study launches.
You'll partner with CRAs, sites, and cross-functional teams, applying GCP/ICH knowledge to maintain TMF/CTMS quality and compliance, while tracking milestones and contributing to project success.
📌 Hybrid Clinical Trial Site Activation Expert (Toronto)
🏢 Immix Biopharma (Nasdaq: IMMX)
📍 Toronto